When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Zanubrutinib - Wikipedia

   en.wikipedia.org/wiki/Zanubrutinib

   Zanubrutinib, sold under the brand name Brukinsa, is an anticancer medication used for the treatment of mantle cell lymphoma (MCL), Waldenström's macroglobulinemia (WM), marginal zone lymphoma (MZL), and chronic lymphocytic leukemia (CLL).

3. US FDA approves expanded use of BeiGene's blood cancer drug - AOL

   www.aol.com/news/us-fda-approves-expanded-bei...

   Brukinsa's approval was based on data from a mid-stage study in which the drug's combination with Gazyva helped destroy or significantly reduce cancerous tumors in patients, compared to Gazyva alone.

4. Mantle cell lymphoma - Wikipedia

   en.wikipedia.org/wiki/Mantle_cell_lymphoma

   Mantle cell lymphoma (MCL) is a type of non-Hodgkin's lymphoma, comprising about 6% of cases. [1] [2] It is named for the mantle zone of the lymph nodes where it develops.[3] [4] The term 'mantle cell lymphoma' was first adopted by Raffeld and Jaffe in 1991.

5. List of herbs with known adverse effects - Wikipedia

   en.wikipedia.org/wiki/List_of_herbs_with_known...

   "Potentiates digitalis activity, increases coronary dilation effects of theophylline, caffeine, papaverine, sodium nitrate, adenosine and epinephrine, increase barbiturate-induced sleeping times" [3] Horse chestnut: conker tree, conker Aesculus hippocastanum: Liver toxicity, allergic reaction, anaphylaxis [3] Kava: awa, kava-kava [4] Piper ...

6. Ozempic before and after: 5 women get real about weight loss ...

   www.aol.com/ozempic-5-women-real-weight...

   Doctors caution against skipping doses of GLP-1 weight-loss drugs like Wegovy because patients who discontinue the medication for a few weeks and then restart it are more likely to have side ...

7. Side effects of bicalutamide - Wikipedia

   en.wikipedia.org/wiki/Side_effects_of_bicalutamide

   These side effects may occur in as many as 90% of men treated with bicalutamide monotherapy, [29] but gynecomastia is generally reported to occur in 70 to 80% of patients. [30] In the EPC trial, at a median follow-up of 7.4 years, breast pain and gynecomastia respectively occurred in 73.6% and 68.8% of men treated with 150 mg/day bicalutamide ...